Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

Bindlish, Shagun; Ng, Jennifer; Ghusn, Wissam; Fitch, Angela; Bays, Harold Edward

doi:10.1016/j.obpill.2023.100092

Cited by 10 publications

(2 citation statements)

References 159 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is known that iliac vein compression at different anatomic locations can cause DVT. Regarding potential causal explanations of CTEPH with PVO, the stasis associated with obstruction, intimal injury of the veins caused by compression, and risk for recurrent DVT serve as mechanistic hypotheses in the pathophysiology of developing CTEPH [ 18 , 19 , 20 ].…”

Section: Discussionmentioning

confidence: 99%

Pelvic Vein Obstruction in Chronic Thromboembolic Pulmonary Hypertension: A Novel Association

Vaidya,

Vaidy,

Al-Otaibi

et al. 2024

JCM

View full text Add to dashboard Cite

Background: Pelvic venous obstruction (PVO), defined as greater than 50% stenosis or occlusion of pelvic veins, is a known risk factor for deep vein thrombosis (DVT). DVT is a known risk factor for chronic thromboembolic pulmonary hypertension (CTEPH), but the prevalence of PVO in CTEPH is unknown. Methods: This cross-sectional study at Temple University’s tertiary referral center for Pulmonary Hypertension, Right Heart Failure, and CTEPH sought to identify the presence of PVO in patients with CTEPH who underwent cardiac catheterization, pulmonary angiography, and venography. Results: A total of 193 CTEPH patients were referred for pulmonary angiography, and among these, 148 underwent venography. PVO was identified in 65 (44%) patients. Lower extremity (LE) DVT was associated with PVO (p = 0.004). The severity of pulmonary hypertension was similar with and without PVO (mean pulmonary artery pressure 43.0 ± 10.3 mm Hg vs. 43.8 ± 12.4 mm Hg, p = 0.70), as was the need for pulmonary thromboendarterectomy (69.2% vs. 61.4%, p = 0.32). Conclusions: Pelvic vein obstruction is common and a novel clinical association in patients with CTEPH, particularly in patients with a history of LE DVT. PVO and its role in CTEPH warrants further study, including the potential role of revascularization to mitigate further risk.

show abstract

Section: Discussionmentioning

confidence: 99%

Pelvic Vein Obstruction in Chronic Thromboembolic Pulmonary Hypertension: A Novel Association

Vaidya,

Vaidy,

Al-Otaibi

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

“…Systemic treatment includes weight reduction among patients with obesity, and routine physical activity. Localized specific treatments include compression stockings and/or surgical procedures such as sclerotherapy and topical laser therapy [24].…”

Section: Discussionmentioning

confidence: 99%

Understanding CEAP Classification: Insights from an Italian Survey on Corona Phlebectatica and Recurrent Active Venous Ulcers by Vascular Specialists

Lessiani,

Gazzabin,

Cocco

et al. 2024

Medicina

View full text Add to dashboard Cite

Background and Objectives: The clinical relevance of “corona phlebectatica” and the management of risk factors for recurrence of venous ulcers in patients with chronic venous disease may be variable based on vascular specialists in different geographical areas of Italy. The aim of the present survey is to evaluate the management of patients with chronic venous disease by vascular specialists in different areas of the national territory. In particular, this involves ascertaining the clinical/prognostic relevance attributed to the presence of the “corona phlebectatica” as well as to the management of risk factors related to recurrence of venous ulcers. Materials and Methods: The web-based survey aimed at vascular medicine specialists with particular interest in venous disease. A questionnaire was developed, based on 12 questions, in relation to clinical assessment, risk factor management, and therapy in patients with chronic venous disease. Results: Almost all of the specialists involved actively participated in the survey, declaring that they personally manage chronic venous disease overall. There was a strong agreement in the prognostic consideration attributed to the presence of “corona phlebectatica” and to the management of risk factors for venous ulcer recurrence, regardless of the different geographical areas of interest. Conclusions: Accordingly with the results of this self-assessment survey, the skills and experience of the specialists involved appear to be of a good standard, both in the clinical evaluation and in the management of the progression of chronic venous disease. However, the need to reach more cultural insights into the correlations between chronic venous disease and risk factors correlated with disease progression emerges. Moreover, there was the need for a greater and tighter overall clinical control of a patient with chronic venous disease, also in relation to the presence of comorbidities.

show abstract

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024

Bays,

Kirkpatrick,

Maki

et al. 2024

Journal of Clinical Lipidology

View full text Add to dashboard Cite

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023

Cited by 10 publications

References 159 publications

Pelvic Vein Obstruction in Chronic Thromboembolic Pulmonary Hypertension: A Novel Association

Pelvic Vein Obstruction in Chronic Thromboembolic Pulmonary Hypertension: A Novel Association

Understanding CEAP Classification: Insights from an Italian Survey on Corona Phlebectatica and Recurrent Active Venous Ulcers by Vascular Specialists

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024

Contact Info

Product

Resources

About